{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:05:32Z","timestamp":1755907532808,"version":"3.44.0"},"reference-count":61,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780323999915"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/b978-0-323-99991-5.00016-4","type":"book-chapter","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T14:28:18Z","timestamp":1680272898000},"page":"441-458","source":"Crossref","is-referenced-by-count":0,"title":["Heart failure: pathophysiology and the emergence of novel therapies"],"prefix":"10.1016","author":[{"given":"Jos\u00e9","family":"Silva-Cardoso","sequence":"first","affiliation":[]},{"given":"Em\u00edlia","family":"Moreira","sequence":"additional","affiliation":[]},{"given":"Diogo","family":"Santos-Ferreira","sequence":"additional","affiliation":[]},{"given":"Adelino","family":"Leite-Moreira","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib1","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"journal-title":"J Card Fail","year":"2021","author":"Bozkurt","key":"10.1016\/B978-0-323-99991-5.00016-4_bib2"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1056\/NEJM199001113220206","article-title":"Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure","volume":"322","author":"Katz","year":"1990","journal-title":"N Engl J Med"},{"year":"2008","series-title":"Heart Failure: Pathophysiology, Molecular Biology, and Clinical Management","author":"Katz","key":"10.1016\/B978-0-323-99991-5.00016-4_bib4"},{"issue":"1","key":"10.1016\/B978-0-323-99991-5.00016-4_bib5","first-page":"85","article-title":"Treatment of heart failure: the relief of symptoms and the improvement of prognosis","volume":"19","author":"Silva-Cardoso","year":"2000","journal-title":"Rev Port Cardiol"},{"issue":"5","key":"10.1016\/B978-0-323-99991-5.00016-4_bib6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/eurheartj\/ehv548","article-title":"Heart failure: when form fails to follow function","volume":"37","author":"Katz","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib7","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1742-1241.2006.00996.x","article-title":"Neurohormones and heart failure: the importance of aldosterone","volume":"60","author":"Odedra","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib8","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1113\/jphysiol.2007.135525","article-title":"Exercise hyperaemia in the heart: the search for the dilator mechanism","volume":"583","author":"Duncker","year":"2007","journal-title":"J Physiol"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ejhf.1059","article-title":"An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology","volume":"20","author":"Louren\u00e7o","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib10","doi-asserted-by":"crossref","first-page":"165739","DOI":"10.1016\/j.bbadis.2020.165739","article-title":"Cardiac ketone body metabolism","volume":"1866","author":"Abdul Kadir","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/A:1020604623427","article-title":"Maladaptive growth in the failing heart: the cardiomyopathy of overload","volume":"16","author":"Katz","year":"2002","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jcmg.2010.10.008","article-title":"Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment","volume":"4","author":"Konstam","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13036-017-0093-0","article-title":"Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure","volume":"12","author":"Fu","year":"2018","journal-title":"J Biol Eng"},{"year":"2006","series-title":"Physiology of the Heart","author":"Katz","key":"10.1016\/B978-0-323-99991-5.00016-4_bib14"},{"issue":"11","key":"10.1016\/B978-0-323-99991-5.00016-4_bib15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3389\/fendo.2020.00617","article-title":"Coordinated modulation of energy metabolism and inflammation by branched-chain amino acids and fatty acids","volume":"8","author":"Ye","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib16","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/ejhf.1154","article-title":"Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function","volume":"20","author":"Hoes","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1016\/B978-0-323-99991-5.00016-4_bib17","doi-asserted-by":"crossref","first-page":"e033486","DOI":"10.1136\/bmjopen-2019-033486","volume":"9","author":"Rocha","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib18","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska","year":"2010","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/B978-0-323-99991-5.00016-4_bib19","first-page":"531","article-title":"CCS\/CHFS Heart Failure Guidelines Update: defining a new pharmacologic standard of care for heart failure with reduced ejection fraction","volume":"37","author":"McDonald","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib20","first-page":"772","volume":"77","author":"Writing","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.yjmcc.2020.05.008","article-title":"A directed network analysis of the cardiome identifies molecular pathways contributing to the development of HFpEF","volume":"144","author":"Summer","year":"2020","journal-title":"J Mol Cell Cardiol"},{"issue":"17","key":"10.1016\/B978-0-323-99991-5.00016-4_bib22","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin\u2013neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/B978-0-323-99991-5.00016-4_bib23","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib24","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/B978-0-323-99991-5.00016-4_bib25","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib26","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib27","first-page":"373","article-title":"Unravelling the molecular basis for cardiac iron metabolism and deficiency in heart failure","volume":"38","author":"Zhabyeyev","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib28","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/archinte.1960.03860170024006","article-title":"Diuretic action of furosemide","volume":"115","author":"Hutcheon","year":"1965","journal-title":"Arch Intern Med"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib29","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1055\/s-0028-1112283","article-title":"Experimental studies and clinical trials of a new diuretic","volume":"88","author":"Kleinfelder","year":"1963","journal-title":"Dtsch Med Wochenschr"},{"issue":"1","key":"10.1016\/B978-0-323-99991-5.00016-4_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10741-020-09995-z","article-title":"Association of loop diuretics use and dose with outcomes in outpatients with heart failure: a systematic review and meta-analysis of observational studies involving 96,959 patients","volume":"27","author":"Kapelios","year":"2022","journal-title":"Heart Fail Rev"},{"issue":"2","key":"10.1016\/B978-0-323-99991-5.00016-4_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ejhf.1369","article-title":"The use of diuretics in heart failure with congestion \u2013 a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Mullens","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"22","key":"10.1016\/B978-0-323-99991-5.00016-4_bib32","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.jacc.2020.04.021","article-title":"Abnormalities of potassium in heart failure: JACC state-of-the-art review","volume":"75","author":"Ferreira","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib33","doi-asserted-by":"crossref","first-page":"e14657","DOI":"10.1097\/MD.0000000000014657","article-title":"Impact of short-acting loop diuretic doses and cardiac sympathetic nerve abnormalities on outcomes of patients with reduced left ventricular function","volume":"98","author":"Onitsuka","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0167-5273(01)00600-3","article-title":"Current evidence supporting the role of diuretics in heart failure: a meta-analysis of randomised controlled trials","volume":"82","author":"Faris","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib35","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/CIRCHEARTFAILURE.112.000178","article-title":"Temporal trends in treatment and outcomes for advanced heart failure with reduced ejection fraction from 1993\u20132010: findings from a university referral center","volume":"6","author":"Loh","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib36","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM198606123142404","article-title":"Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study","volume":"314","author":"Cohn","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib37","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib38","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/01.CIR.90.4.1765","article-title":"of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees","volume":"90","author":"A randomized trial","year":"1994","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/B978-0-323-99991-5.00016-4_bib39","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib40","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(00)02213-3","article-title":"Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial\u2014the Losartan Heart Failure Survival Study ELITE II","volume":"355","author":"Pitt","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib41","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition vs enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib42","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib43","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/B978-0-323-99991-5.00016-4_bib44","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/1753-0407.13007","article-title":"Cardiorenal protection with SGLT2: lessons from the cardiovascular outcome trials","volume":"12","author":"Silva-Cardoso","year":"2020","journal-title":"J Diabetes"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib45","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/XCE.0000000000000150","article-title":"Cardioprotective glucose-lowering medications: evidence and uncertainties in a new therapeutic era","volume":"7","author":"Krentz","year":"2018","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib46","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCULATIONAHA.120.052926","article-title":"How should we sequence the treatments for heart failure and a reduced ejection fraction?: a redefinition of evidence-based medicine","volume":"143","author":"McMurray","year":"2021","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/B978-0-323-99991-5.00016-4_bib47","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.repc.2021.07.009","article-title":"Optimization of heart failure with reduced ejection fraction prognosis-modifying drugs: a 2021 heart failure expert consensus paper","volume":"40","author":"Silva-Cardoso","year":"2021","journal-title":"Rev Port Cardiol (Engl Ed)"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib48","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2014.12.018","volume":"66","author":"Hicks","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib49","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jacc.2018.11.049","article-title":"Clinical course of patients with worsening heart failure with reduced ejection fraction","volume":"73","author":"Butler","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib50","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/ejhf.1492","article-title":"Acute heart failure congestion and perfusion status\u2014impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry","volume":"21","author":"Chioncel","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/B978-0-323-99991-5.00016-4_bib51","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/eurheartj\/ehs444","article-title":"Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial","volume":"34","author":"Ambrosy","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib52","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/ejhf.890","article-title":"Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib53","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib54","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2025797","article-title":"Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure","volume":"384","author":"Teerlink","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib55","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jvim.15454","article-title":"The renin-angiotensin-aldosterone system and its suppression","volume":"33","author":"Ames","year":"2019","journal-title":"J Vet Intern Med"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib56","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10741-020-10069-3","article-title":"Management of RAASi-associated hyperkalemia in patients with cardiovascular disease","volume":"26","author":"Silva-Cardoso","year":"2021","journal-title":"Heart Fail Rev"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib57","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(19)32135-X","article-title":"Patiromer vs placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"394","author":"Agarwal","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib58","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jacc.2021.01.044","article-title":"Interplay of mineralocorticoid receptor antagonists and empagliflozin in heart failure: EMPEROR-Reduced","volume":"77","author":"Ferreira","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib59","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jchf.2020.11.009","article-title":"Dapagliflozin in HFrEF patients treated with mineralocorticoid receptor antagonists: an analysis of DAPA-HF","volume":"9","author":"Shen","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib60","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/B978-0-323-99991-5.00016-4_bib61","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Cardiovascular Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780323999915000164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780323999915000164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T05:53:50Z","timestamp":1755842030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780323999915000164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780323999915"],"references-count":61,"URL":"https:\/\/doi.org\/10.1016\/b978-0-323-99991-5.00016-4","relation":{},"subject":[],"published":{"date-parts":[[2023]]}}}